How to Treat Patients with Bleeding Disorder of Unknown Cause?

Overview

Journal Res Pract Thromb Haemost

Publisher Elsevier

Date 2024 Nov 11

PMID 39526290

Authors

Caroline Mussert

Amaury Monard

Floor Heubel-Moenen

Affiliations

Soon will be listed here.

References

Macdonald S, Wright A, Beuche F, Downes K, Besser M, Symington E . Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment. Int J Lab Hematol. 2019; 42(2):116-125. DOI: 10.1111/ijlh.13124. View

Berkowitz C, Ma A, Miller V, Goraya S, Kirkland K, Grabell J . Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause. Res Pract Thromb Haemost. 2024; 8(7):102572. PMC: 11532456. DOI: 10.1016/j.rpth.2024.102572. View

Gebhart J, Hofer S, Panzer S, Quehenberger P, Sunder-Plassmann R, Hoermann G . High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB). Haemophilia. 2018; 24(3):405-413. DOI: 10.1111/hae.13422. View

Baker R, Choi P, Curry N, Gebhart J, Gomez K, Henskens Y . Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH. J Thromb Haemost. 2024; 22(7):2059-2070. DOI: 10.1016/j.jtha.2024.03.005. View

Castle D, Desborough M, Kemp M, Lowe G, Thomas W, Obaji S . Outcomes and management of pregnancy in women with bleeding disorder of unknown cause. J Thromb Haemost. 2022; 20(11):2519-2525. DOI: 10.1111/jth.15871. View

Cohn C . Platelet transfusion refractoriness: how do I diagnose and manage?. Hematology Am Soc Hematol Educ Program. 2020; 2020(1):527-532. PMC: 7727584. DOI: 10.1182/hematology.2020000137. View

Mehic D, Neubauer G, Janig F, Kaider A, Ay C, Pabinger I . Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank. J Thromb Haemost. 2023; 21(7):1757-1768. DOI: 10.1016/j.jtha.2023.03.006. View

Veen C, Huisman E, Romano L, Schipaanboord C, Cnossen M, de Maat M . Outcome of Surgical Interventions and Deliveries in Patients with Bleeding of Unknown Cause: An Observational Study. Thromb Haemost. 2021; 121(11):1409-1416. DOI: 10.1055/s-0041-1726344. View

Obaji S, Alikhan R, Rayment R, Carter P, Macartney N, Collins P . Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and/or desmopressin. Haemophilia. 2015; 22(2):285-291. DOI: 10.1111/hae.12811. View

10.

Quiroga T, Goycoolea M, Panes O, Aranda E, Martinez C, Belmont S . High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica. 2007; 92(3):357-65. DOI: 10.3324/haematol.10816. View

11.

Baker R, ODonnell J . How I treat bleeding disorder of unknown cause. Blood. 2021; 138(19):1795-1804. PMC: 9642789. DOI: 10.1182/blood.2020010038. View

12.

Li L, Johnsen J, Doan C, Bollag L . Case Report: Anesthetic management for Cesarean section in a parturient with unspecified inherited bleeding disorder. F1000Res. 2018; 7:1482. PMC: 6283378. DOI: 10.12688/f1000research.16097.2. View